Ascaphin-8

General Information


DRACP ID  DRACP02465

Peptide Name   Ascaphin-8

Sequence  GFKDLLKGAAKALVKTVLF

Sequence Length  19

UniProt ID  P0CJ32 

PubChem CID  16143925 

Origin  Ascaphus truei

Type  Native peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma LC50=20 µM CytoTox 96 non-radiactive cytotoxicity assay  1 h 1

Hemolytic Activity  Human erythrocytes: LC50=55 µM

Normal (non-cancerous) Cytotoxicity  L929 fibroblast-derived cells: LC50=7 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02465

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C97H163N23O23

Absent amino acids  CEHIMNPQRSWY

Common amino acids  KL

Mass  234077

Pl  10.8

Basic residues  4

Acidic residues  1

Hydrophobic residues  11

Net charge  3

Boman Index  754

Hydrophobicity  73.68

Aliphatic Index  128.42

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18554256

Title  Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7

Doi 10.1111/j.1747-0285.2008.00671.x

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_2300

DRACP is developed by Dr.Zheng's team.